ACE and metabolic syndrome: Shang et al. have reported lower serum omentin-1 levels in patients with MetS (23% on statins and 32% on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers) [57]; however, they did not correct for the increased BMI and waist circumference.